Consumer Health

Ecuador is expected to register only a slight increase in current value sales in 2023. Ecuador is grappling with rising crime rates and political instability, with runoff elections scheduled in October. This is all leading to economic uncertainty and…

Consumer health in France continues to experience growth in 2023. Due to the pandemic, consumers’ immune systems have been negatively impacted. The French healthcare system remains weak and 2022 and 2023 have faced multiple challenges, including a…

Inflation is a key factor influencing the consumer health market in Greece, with price hikes being seen across most categories. Even though increases in prices vary by brand, most products have been subject to hikes. This has not had the same effect…

Consumer health is witnessing another strong performance in 2023 as the category continues to recover from the COVID-19 pandemic following the removal of all pandemic-related restrictions. As Irish people shift back to normal living habits without…

Consumer health is expected to register a healthy pace of current value growth in 2023. After a successful vaccination programme in 2021, society opened up quickly in Israel. With society returning to greater normality in 2023, common illnesses are…

Consumer health is set to record moderate single-digit growth in current value terms in 2023. With the pandemic officially over, according to the World Health Organisation (WHO), Italians are keen to get back to their pre-COVID-19 lifestyles and this…

Total current value sales growth for consumer health in Morocco in 2023 is expected to be up considerably on 2022. While this is partly due to inflationary pressures fuelled by the global recovery from the pandemic and the fallout of Russia’s…

2023 saw a repeat of the moderate, sustainable growth that was registered in most categories of consumer health during 2022, with the prevailing background trends characterised by a return to some semblance of pre-pandemic normality in the daily…

The Coronavirus (COVID-19) pandemic had a major impact on almost every category within consumer health in the Netherlands. While the COVID-19 situation eased by 2022, 2023 is the first full year after the pandemic in which players, retailers and…

2023 is set to be a strong year for consumer health in the United Arab Emirates. Many categories are expected to see robust current value growth, underpinned by an increase in online distribution channels, as well as an increasingly savvy,…

While 2022 was characterised by high inflation, persisting supply chain constraints, and the ongoing war in Ukraine, which brought price increases and volume declines across much of consumer health, it benefited from waning COVID-19 cases and the…

Current value sales of consumer health in Vietnam continue to record strong growth in line with the rising trend of health and wellness in the country. Post-pandemic, the majority of Vietnamese consumers are taking greater care of their health, and…

Cough, cold and allergy (hay fever) remedies are expected to perform better in 2023 than in the previous year, with positive value and volume growth. As life in Algeria returns to normal, and social contact increases, there is increased coughs, colds…

Retail sales of cough, cold and allergy (hay fever) remedies saw another year of healthy growth in constant value terms in 2023. With the resumption of pre-pandemic lifestyles, including a return to work, school and social activities, consumers…

Sales of cough, cold and allergy (hay fever) remedies are seeing strong growth in current value terms in 2023. This is partly due to inflation-driven price increases (also the consequence of supply shortages in some cases) and an increase in cough,…

Seasonal flus have returned, as people mix together once again , post pandemic, and cough, cold and allergy (hay fever remedies) are expected to register moderate current value growth, though constant value growth will be minimal, as rising costs hit…

Cough, cold and allergy (hay fever) continues to rebound following the declines during the COVID-19 pandemic and the slow recovery in its aftermath. Unit prices have been driven up by inflation resulting in double-digit current value growth in 2023,…

Cough and cold remedies/products are expected to enjoy demand in 2023. However, the shortages of cough and cold medicines, which provided a consistent disruption in 2022, lingered in 2023. Against this background, manufacturers have struggled to keep…

Cough, cold, and allergy (hay fever) remedies in Chile is experiencing remarkable growth for the second consecutive year in 2023, both in terms of volume and value. This upward trend can be attributed primarily to the return to normalcy following the…

Even though cough, cold and allergy (hay fever) remedies recorded over 40% current value growth in 2022, it is anticipated that the category will continue to achieve high single-digit growth in 2023. Starting from late 2022, the end of the zero-COVID…